61 related articles for article (PubMed ID: 1343283)
21. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
22. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
[TBL] [Abstract][Full Text] [Related]
23. [Manidipine in the treatment of stage I and II essential hypertension patients with overweight or android obesity. A Brazilian multicentre study of efficacy, tolerability and metabolic effects].
Kohlmann O; Ribeiro AB;
Arq Bras Cardiol; 2001 Nov; 77(5):463-70. PubMed ID: 11733819
[TBL] [Abstract][Full Text] [Related]
24. Hypertension in the elderly: 24 h ambulatory blood pressure results from a placebo-controlled trial.
Neutel JM; Smith DH; Lefkowitz MP; Cargo P; Alemayehu D; Weber MA
J Hum Hypertens; 1995 Sep; 9(9):723-7. PubMed ID: 8551485
[TBL] [Abstract][Full Text] [Related]
25. Effects on urinary albumin excretion and renal function changes by delapril and manidipine in normotensive type 2 diabetic patients with microalbuminuria.
Deerochanawong C; Kornthong P; Phongwiratchai S; Serirat S
J Med Assoc Thai; 2001 Feb; 84(2):234-41. PubMed ID: 11336083
[TBL] [Abstract][Full Text] [Related]
26. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
27. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
[TBL] [Abstract][Full Text] [Related]
29. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of manidipine in the treatment of hypertension with renal impairment: a multicenter trial.
Saruta T; Suzuki H
Am Heart J; 1993 Feb; 125(2 Pt 2):630-4. PubMed ID: 8430609
[TBL] [Abstract][Full Text] [Related]
31. Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: a multicenter randomized controlled trial.
Bellinghieri G; Mazzaglia G; Savica V; Santoro D
Ren Fail; 2003 Sep; 25(5):681-9. PubMed ID: 14575277
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic profile of manidipine and lercanidipine in hypertensive patients.
Casiglia E; Mazza A; Tikhonoff V; Basso G; Martini B; Scarpa R; Pessina AC
Adv Ther; 2004; 21(6):357-69. PubMed ID: 15856859
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of efficacy and safety of manidipine hydrochloride among essential hypertensive patients: Substitution from branded product (Calslot) to Generic Product (Manidip)].
Kobayashi H; Obara T; Takahashi N; Takahashi T; Igari Y; Oikawa T; Saito S; Ohkubo T; Imai Y; Takahashi M
Yakugaku Zasshi; 2007 Dec; 127(12):2045-50. PubMed ID: 18057792
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and mode of action of manidipine: a new calcium antagonist.
Iimura O; Shimamoto K
Am Heart J; 1993 Feb; 125(2 Pt 2):635-41. PubMed ID: 8430610
[TBL] [Abstract][Full Text] [Related]
35. Closing remarks: current position of calcium channel antagonists in hypertension--the role of manidipine.
Zanchetti A
Drugs; 2005; 65 Suppl 2():40-2. PubMed ID: 16398061
[No Abstract] [Full Text] [Related]
36. [Quality of life and the treatment of hypertension in the elderly].
Fujisawa T; Ogihara T
Nihon Ronen Igakkai Zasshi; 2007 Jul; 44(4):452-5. PubMed ID: 17827801
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of hypertension and QOL assessment].
Mikami H
Nihon Rinsho; 2000 Feb; 58 Suppl 2():36-9. PubMed ID: 11028289
[No Abstract] [Full Text] [Related]
38. Importance of well-being to hypertensive patients.
Seedat YK
S Afr Med J; 1989 Oct; Suppl():24. PubMed ID: 2799567
[No Abstract] [Full Text] [Related]
39. Treatment of hypertension in older adults.
Hand CH
BMJ; 1992 Mar; 304(6827):639. PubMed ID: 1559101
[No Abstract] [Full Text] [Related]
40. Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study.
Baig MH; Sharma T; Ahmad I; Abohashrh M; Alam MM; Dong JJ
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
